These data also indicate that differences in Myc regulation may be at least partially responsible for menin’s switch from being a tumor promoter in AR-positive prostate cancers to a tumor suppressor in some AR-negative prostate cancers since menin has opposing effects on Myc expression in prostate cancer cell lines depending on whether AR is expressed. The gene discussed is MYC; the disease is prostate cancer.